Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Bumol

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cellsJ R Harper, T F Bumol, R A Reisfeld
Hybridoma|January 1, 1982
Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigenT F Bumol, D O Chee, R A Reisfeld
International Journal of Cancer|February 20, 1993
The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1J Hoskins, S V DeHerdt, R E Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growthT F Bumol, Q C Wang, R A Reisfeld, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude miceM E Spearman, R M Goodwin, L D Apelgren, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Antigenic expression of human melanoma cells in serum-free mediumT F Bumol, J R Harper, D O Chee, et al.
Cancer Research|May 1, 1991
The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studiesB H Petersen, S V DeHerdt, D W Schneck, et al.
Cancer Research|June 15, 1990
Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancerL D Apelgren, D L Zimmerman, S L Briggs, et al.
Hybridoma|August 1, 1988
Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibodyT F Bumol, P Marder, S V DeHerdt, et al.
Biotechnology and Applied Biochemistry|December 1, 1988
Isolation and characterization of the human adenocarcinoma-associated glycoprotein gp40J R Sportsman, L D Taber, M C Slisz, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cellsJ R Harper, T F Bumol, R A Reisfeld
Hybridoma|January 1, 1982
Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigenT F Bumol, D O Chee, R A Reisfeld
International Journal of Cancer|February 20, 1993
The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1J Hoskins, S V DeHerdt, R E Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growthT F Bumol, Q C Wang, R A Reisfeld, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude miceM E Spearman, R M Goodwin, L D Apelgren, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Antigenic expression of human melanoma cells in serum-free mediumT F Bumol, J R Harper, D O Chee, et al.
Cancer Research|May 1, 1991
The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studiesB H Petersen, S V DeHerdt, D W Schneck, et al.
Cancer Research|June 15, 1990
Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancerL D Apelgren, D L Zimmerman, S L Briggs, et al.
Hybridoma|August 1, 1988
Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibodyT F Bumol, P Marder, S V DeHerdt, et al.
Biotechnology and Applied Biochemistry|December 1, 1988
Isolation and characterization of the human adenocarcinoma-associated glycoprotein gp40J R Sportsman, L D Taber, M C Slisz, et al.
Pageof 3